FindTrial
Sign In

Topical corticosteroid administration in diabetes patients who underwent total hip arthroplasty due to osteoarthritis increases risk of periprosthetic joint infection: a retrospective case-control study

Topical corticosteroid administration in diabetes patients who underwent total hip arthroplasty due to osteoarthritis increases risk of periprosthetic joint infection: a retrospective case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031611
Enrollment
Unknown
Registered
2020-04-05
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Experimental group:topical corticosteroid administration
Control group:without toplcal corticosteroid administration

Sponsors

The First Affiliatd Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diabetic patients with primary knee osteoarthritis; 2. Patients aged 55-80.

Exclusion criteria

Exclusion criteria: 1. Patients with inflammatory arthritis; 2. Patients with infectious arthritis; 3. Neuropathic arthropathy; 4. Patients with poor insulin resistance or diabetes control; 5. Patients with knee joint revision; 6. Tumor patients; 7. Patients who cannot cooperate with follow-up; 8. Patients with neuropsychiatric disorders.

Design outcomes

Primary

MeasureTime frame
the rate of periprosthetic joint infection;—

Secondary

MeasureTime frame
superficial wound problems;—

Countries

China

Contacts

Public ContactWenjun Feng

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

foreverarsene@126.com+86 13802446713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026